arrow
R

Ricardo T. Gazzinelli

centro de tecnologia de vacinas
H指数:90
被引数:3.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comprehensive Stability Assessment of Squalene in a Nanoemulsion Adjuvant and the SpiN-Tec Vaccine: HPLC Quantification, Stress Testing, and Stability Studies

角鲨烯在纳米乳佐剂和SpiN-Tec疫苗中的综合稳定性评估:HPLC定量、应力测试和稳定性研究

2026-09-180
OAAI
Correction: RNA and protein immunization with Trypanosoma cruzi trans-sialidase containing SAPA repeats protects mice against infection and promotes a balanced inflammatory response

更正:使用含有SAPA重复序列的克氏锥虫转涎酶进行RNA和蛋白质免疫,可保护小鼠免受感染并促进平衡的炎症反应。

2025-11-060
OAAI
RNA and protein immunization with Trypanosoma cruzi trans-sialidase containing SAPA repeats protects mice against infection and promotes a balanced inflammatory response

RNA和蛋白质免疫接种含SAPA重复序列的克氏锥虫转唾液酸酶可保护小鼠免受感染并促进平衡的炎症反应

2025-10-170
OAAI
Safety and immunogenicity of SpiN-Tec, a T-cell based RBD-Nucleocapsid chimeric vaccine for COVID-19

SpiN-Tec的安全性和免疫原性,一种基于T细胞的COVID-19 RBD-核衣壳嵌合疫苗

Vaccine
IF3.5
2025-09-190
OAAI
Safety and efficacy of an intramuscular bivalent vaccine against influenza and Streptococcus pneumoniae infections in mice

小鼠中针对流感及肺炎链球菌感染的二价肌肉注射疫苗的安全性与有效性

2025-08-290
PRE
A universal point-of-care immunochromatographic test for the serodiagnosis of hepatitis D

一种用于丁型肝炎血清学诊断的通用床旁免疫层析试验

2025-05-140
OA
Asymptomatic vivax malaria is associated with an IFN-γ-program on adaptive immunity

无症状间日疟与IFN-γ调控的适应性免疫程序相关

2025-03-190
OA
Cytotoxic Signature and IFN-γ Production Dominate CD4+ T-Cell Response During Human Toxoplasmosis

细胞毒性特征和IFN-γ产生主导人类弓形虫病期间的CD4+ T细胞反应

2025-03-040
OA
Intranasal influenza-vectored vaccine expressing pneumococcal surface protein A protects against Influenza and Streptococcus pneumoniae infections
2024-12-190
OAAI
SARS-CoV-2 Rapid Antigen Test Based on a New Anti-Nucleocapsid Protein Monoclonal Antibody: Development and Real-Time Validation

基于新型抗核衣壳蛋白单克隆抗体的SARS-CoV-2快速抗原检测: 开发和实时验证

2023-09-280
OAAI
ASP-2/Trans-sialidase chimeric protein induces robust protective immunity in experimental models of Chagas' disease
2023-05-317
OAAI
Differential requirement of neutralizing antibodies and T cells on protective immunity to SARS-CoV-2 variants of concern
2023-02-139
OAAI